Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Aneurysm & intracranial embolization · Texas | Aneurysm & intracranial embolization · Florida | |
|---|---|---|
| Surgeons, 2024 | 28 | 40 |
| Medicare fee-for-service cases | 1,099 | 1,299 |
| Growth since 2019 (Medicare FFS) | +13%/yr | +18%/yr |
| Forecast cases (Medicare FFS) | 2,130 in 2030 | 2,280 in 2030 |
| Forecast growth | +12%/yr to 2030 | +9.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.5 | 0.6 |
| Medicare Advantage share | 59% | 60% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 39 | 32 |
| Top 10 surgeons' share | 52% | 39% |
| Surgeons growing | 2 | 4 |
| New since the base year | 13 | 10 |
| Likely to stop billing it | 13 by 2026 | 14 by 2026 |
| Forecast miss, 1 year (procedure) | 13% | 13% |
| Company payments per surgeon | $17K | $14K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.